TrialClinical oral investigations2014
Prevalence of bisphosphonate-associated osteonecrosis of the jaw after intravenous zoledronate infusions in patients with early breast cancer.
Petra Rugani et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this paperpooled ittrialcites it